So-Young (SY) Q2 FY26 earnings call

So-Young delivered a robust Q2 FY26, achieving record group revenue and significantly narrowing net losses, primarily driven by the strong performance of its aesthetic treatment business. The company focused on clinic expansion, operational efficiency, and AI integration, while also deepening supply chain collaborations to enhance product offerings and profitability. Management is confident in achieving group-level profitability through continued growth and cost optimization.